SCHEMBL5280489

SCHEMBL5280489

CC(C)=NN=c1scc(-c2ccc(Br)cc2)n1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.40
LMNA P02545 3/20 0.40
MAPK1 P28482 3/20 0.40
HTT P42858 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CA12 O43570 3/20 0.37
CA2 P00918 3/20 0.37
CA9 Q16790 3/20 0.37
CA1 P00915 2/20 0.37
IDO1 P14902 3/20 0.36
PTGS2 P35354 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
EGFR P00533 2/20 0.33
DHFR P00374 1/20 0.33
ERBB2 P04626 1/20 0.33
MAPT P10636 5/20 0.32
TDP1 Q9NUW8 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5280481 1.00 SMN1; SMN2 (0.40) SMN1; SMN2LMNAMAPK1HTTNPSR1
SCHEMBL5284067 0.87 MAPT (0.42) SMN1; SMN2LMNAMAPK1HTTALDH1A1
SCHEMBL5278228 0.85 SMN1; SMN2 (0.41) SMN1; SMN2LMNAMAPK1HTTALDH1A1
SCHEMBL5278424 0.85 MAPT (0.39) SMN1; SMN2LMNAMAPK1HTTALDH1A1
SCHEMBL5278421 0.85 MAPT (0.39) SMN1; SMN2LMNAMAPK1HTTALDH1A1
SCHEMBL5283771 0.85 SMN1; SMN2 (0.43) SMN1; SMN2LMNAMAPK1HTTALDH1A1
SCHEMBL5283764 0.85 SMN1; SMN2 (0.43) SMN1; SMN2LMNAMAPK1HTTALDH1A1
SCHEMBL5285390 0.83 ALDH1A1 (0.35) SMN1; SMN2LMNAMAPK1HTTNPSR1
SCHEMBL5285396 0.83 ALDH1A1 (0.35) SMN1; SMN2LMNAMAPK1HTTNPSR1
SCHEMBL5287532 0.83 MAPT (0.49) SMN1; SMN2LMNAMAPK1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT SMN1; SMN2 3523/4885LMNA 1094/4885MAPK1 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.